Want to see ZEPP full AI Analyst Report?
Zepp Health (ZEPP) Stock Statistics & Valuation Metrics
Total Valuation
Zepp Health has a market cap or net worth of $32.30M. The enterprise value is $222.21M.
- Market Cap
- $32.30M
- Enterprise Value
- $222.21M
Share Statistics
Zepp Health has 8,460,126 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,460,126
- Owned by Insiders
- 13.77%
- Owned by Institutions
- 6.67%
Financial Efficiency
Zepp Health’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -6.58%.
- Return on Equity (ROE)
- -0.19
- Return on Assets (ROA)
- -0.07
- Return on Invested Capital (ROIC)
- -6.58%
- Return on Capital Employed (ROCE)
- -0.11
- Revenue Per Employee
- 2.38M
- Profits Per Employee
- -368.18K
- Employee Count
- 763
- Asset Turnover
- 0.46
- Inventory Turnover
- 2.17
Valuation Ratios
The current PE Ratio of Zepp Health is -0.05. Zepp Health’s PEG ratio is 0.00.
- PE Ratio
- -0.05
- PS Ratio
- 0.11
- PB Ratio
- 0.01
- Price to FCF
- -1.13
- Price to Operating Cash Flow
- -0.08
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Zepp Health had revenue of 1.82B and earned -280.92M in profits. Earnings per share was -283.04.
- Revenue
- 1.82B
- Gross Profit
- 711.63M
- Operating Income
- -204.93M
- Pretax Income
- -263.13M
- Net Income
- -280.92M
- EBITDA
- -191.48M
- Earnings Per Share (EPS)
- -283.04
Cash Flow
In the last 12 months, operating cash flow was -179.65M and capital expenditures -5.48M, giving a free cash flow of -185.14M billion.
- Operating Cash Flow
- -179.65M
- Free Cash Flow
- -185.14M
- Free Cash Flow per Share
- -187.07
Dividends & Yields
Zepp Health pays an annual dividend of $0.10, resulting in a dividend yield of ―
- Dividend Per Share
- $0.10
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -88.42%
- Earnings Yield
- -2083.82%
Stock Price Statistics
- Beta
- 1.29
- 52-Week Price Change
- -94.42%
- 50-Day Moving Average
- 3.95
- 200-Day Moving Average
- 9.94
- Relative Strength Index (RSI)
- 11.44
- Average Volume (3m)
- 47.55K
Important Dates
Zepp Health upcoming earnings date is Nov 23, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 02, 2026
- Next Earnings Date
- Nov 23, 2026
- Ex-Dividend Date
- Mar 25, 2022
Financial Position
Zepp Health as a current ratio of 1.02, with Debt / Equity ratio of 106.29%
- Current Ratio
- 1.02
- Quick Ratio
- 0.77
- Debt to Market Cap
- 59.27
- Net Debt to EBITDA
- -4.20
- Interest Coverage Ratio
- -5.13
Taxes
In the past 12 months, Zepp Health has paid 17.79M in taxes.
- Income Tax
- 17.79M
- Effective Tax Rate
- -0.07
Enterprise Valuation
Zepp Health EV to EBITDA ratio is -4.57, with an EV/FCF ratio of -6.25.
- EV to Sales
- 0.60
- EV to EBITDA
- -4.57
- EV to Free Cash Flow
- -6.25
- EV to Operating Cash Flow
- -6.44
Balance Sheet
Zepp Health has $721.36M in cash and marketable securities with $1.67B in debt, giving a net cash position of -$948.34M billion.
- Cash & Marketable Securities
- $721.36M
- Total Debt
- $1.67B
- Net Cash
- -$948.34M
- Net Cash Per Share
- -$112.10
- Tangible Book Value Per Share
- $1,115.10
Margins
Gross margin is 39.12%, with operating margin of -12.43%, and net profit margin of -15.64%.
- Gross Margin
- 39.12%
- Operating Margin
- -12.43%
- Pretax Margin
- -14.73%
- Net Profit Margin
- -15.64%
- EBITDA Margin
- -13.15%
- EBIT Margin
- -13.51%
Analyst Forecast
The average price target for Zepp Health is $43.86, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $43.86
- Price Target Upside
- 1893.64% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 38.14%
- EPS Growth Forecast
- 43.05%
Scores
- Smart Score
- 3
- AI Score
- 44
